HC Wainwright Brokers Lower Earnings Estimates for AVDL
Avadel Pharmaceuticals plc (NASDAQ:AVDL – Free Report) – Investment analysts at HC Wainwright cut their Q2 2025 earnings per share (EPS) estimates for shares of Avadel Pharmaceuticals in a research note issued on Tuesday, March 4th. HC Wainwright analyst O. Livnat now forecasts that the company will post earnings per share of ($0.06) for the […]
